Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Learn more about REXULTI for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

Investigation Questions Drug's Approval for Agitation in AD

A silent struggle: Caregiving for a patient with agitation associated with dementia due to Alzheimer's disease - STAT

FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients

FDA Approves Rexulti for Treating Agitation Due to Alzheimer's - MyChesCo

Otsuka and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application (sNDA) for REXULTI® ( brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer's Disease

Otsuka, Lundbeck's sNDA for Rexulti received US FDA approval

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

REXULTI®(brexpiprazole)

Medicare coverage debates amplify as FDA approves Rexulti for Alzheimer's agitation

Frontiers Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions

Pyrls on Instagram: Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation associated with dementia due to Alzheimer's disease ✨ Learn more about brexpiprazole in your Pyrls app or

FDA Approves Rexulti For Agitation Associated With Dementia Due To Alzheimer's

Rexulti (Brexpiprazole): Side Effects, Use for Depression, and More